Author/Authors :
Kim, Ji Hyun School of Medicine - University of California - Los Angeles - California, USA , Caprioli, Joseph School of Medicine - University of California - Los Angeles - California, USA
Abstract :
Elevated intraocular pressure (IOP) is a major risk factor for the development and progression of glaucoma.
Previous prospective, randomized, long‑term studies have demonstrated the strength of IOP reduction in
slowing the progression of disease. It is well known that IOP is not a fixed value but fluctuates considerably
over time. Although there have been some studies on IOP fluctuation and the progression of glaucoma,
whether IOP fluctuation is an independent risk factor for glaucomatous damage and disease progression
remains controversial. In this article, we reviewed the definition of IOP fluctuation, and both the evidence
and the speculation for and against the effect of IOP fluctuation on glaucoma progression. Although
conclusions seem to vary from study to study, we considered that different studies examined different
groups of patients, at different stages of disease, and at different IOP levels. Our conclusion is that these
apparently disparate results are not conflicting, but rather can be viewed as complementary. In clinical care,
we recommend the consideration of IOP “modulation” rather than just IOP “reduction” when glaucoma
patients are treated. Quality‑based IOP control may be more effective than quantity‑based IOP reduction
to prevent or retard disease progression.